Spending power
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Brand profile · Pharmaceutical Manufacturing
Helius Therapeutics is a Pharmaceutical Manufacturing brand in East Tamaki, Auckland. Ownership is privately held; it publishes at helius.com. It holds one address on record, all in New Zealand. The record counts 36 people. Tagged marketing, nutraceuticals and horticulture. Its latest round on record is Grant, US$57.0K. It is listed alongside seven similar brands, mostly in Pharmaceutical Manufacturing.
Helius Therapeutics helps people improve their quality of life through safe and effective medicinal cannabis products.
We are a New Zealand-owned company with facilities in Auckland. Helius specialises in the cultivation, research and manufacturing of GMP-certified medicinal cannabis products.
Our executive leadership team comprises leading professionals from pharmaceuticals, horticulture, marketing, operations and financial sectors.
Helius is creating a naturally healthier society and shares a vision of improving the quality of life for all New Zealanders who can benefit from locally-produced, quality medicinal cannabis.
This page is monitored Monday-Friday between standard business operating hours.
NB: Information contained on this page was developed for a New Zealand audience and may not comply with regulatory requirements in other countries.
For more information visit: www.helius.co.nz.
| Countries | 1 |
|---|---|
| Primary country | NZ |
All codes: NZ
| Rounds | 6 |
|---|---|
| Axis | 2018 to 2026 |
| Grant · 20 Jun 2024 | US$ 57.0K |
Dated rounds only. The axis ends at the date this profile was last observed, not at today.
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Hiring, headcount and registry-change signals, streamed to members.
Registry-filed capital and financial indicators, standardised by TheGrid.
4 employee profiles on record · names withheld.
Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.
Counts only. No names are stored here, and none are served.
The record holds 36 counted staff profiles at January 2026, inside the self-reported 11–50 band.
One address on record, New Zealand only. Primary: 18 Ron Driver Pl, East Tamaki, Auckland 2013.
Six rounds. Latest 20 June 2024: grant, US$57,000, investor Callaghan Innovation.
Eight tags on the brand's own list, among them marketing, nutraceuticals and horticulture.
23 profiles list Helius Therapeutics as a peer — 95th percentile in Pharmaceutical Manufacturing. It lists ten peers of its own. Rua Bioscience and Cannasouth Bioscience Limited list it back.